We report a case of a 51-year-old man who received a cadaveric liver allograft for autoimmune and hepatopulmonary syndrome. The patient was admitted with symptoms of progressive vomiting and diarrhea 16 months after transplantation. Laboratory studies showed abnormal liver functions, and abdominal magnetic resonance imaging (MRI) showed a 76-mm heterogeneous mass in the liver. Histological examination showed a malignant lymphoid neoplasm with plasmablastic features. Plasmablastic lymphoma (PL) is rare in the post-transplantation period. To the best of our knowledge, only 25 well-documented cases of posttransplant PL, including ours, have been described.
SwerdlowSHWebberSAChadburnAFerryJA. Post-transplant lymphoproliferative disorders. In: SwerdlowSHCampoEHarrisNL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed.Lyon, France: IARC Press; 2008:343-349.
2.
JagadeeshDWodaBADraperJ. Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations. Curr Treat Options Oncol. 2012;13: 122-136.
3.
ValbuenaJRRetamalYBernalC. Epstein-Barr virus associated primary lymphoepithelioma-like carcinoma of the esophagus. Diagn Mol Pathol. 2007;16:27-31.
4.
SteinHHarrisNLCampoE. Plasmablastic lymphoma. In: SwerdlowSHCampoEHarrisNL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed.Lyon, France: IARC Press; 2008:256-257.
5.
HisEDLorsbachRBFendFDoganA. Plasmablastic lymphoma and related disorders. Am J Clin Pathol. 2011;136:183-194.
6.
PaternosterSFBrockmanSRMcClureRF. A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase flourescence in situ hybridization. Am J Pathol. 2002;160:1967-1972.
7.
BarkholtLBillingHJuliussonGPorwitAEriczonBGGrothCG. B-cell lymphoma in transplanted liver: clinical, histological and radiological manifestations. Transpl Int. 1991;4:8-11.
8.
DuvouxCPageauxGPVanlemmensC. Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients. Transplantation. 2002;74:1103-1109.
9.
JainANalesnikMReyesJ. Posttransplant lymphopropliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002;236:429-436.
10.
RoqueJRiosGHumeresR. Early posttransplant lymphoproliferative disease in pediatric liver transplant. Transplant Proc. 2006;38:930-931.
11.
AvolioAWAgnesSBarbarinoR. Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patients series. Transplant Proc. 2007;39:1956-1960.
12.
JainAPatilVPFungJ. Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up. Liver Transpl. 2008;14:1406-1411.
13.
AbergFPukkalaEHockerstedtKSankilaRIsoniemiH. Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl. 2008;14: 1428-1436.
14.
IzadiMFazelMSaadatSHTaheriS. Hepatic involvement by lymphoproliferative disorders post liver transplantation: PTLD. Int. Survey. Hepatol Int. 2011;5:759-766.
15.
HegabBKhalafHAllamN. De novo malignancies after liver transplantation: a single-center experience. Ann Saudi Med. 2012;32:355-358.
16.
SpiroIJYandellDWLiC. Brief report: lymphoma of donor origin occurring in the porta hepatis of a transplanted liver. N Engl J Med. 1993;329:27-29.
17.
ArmesJEAngusPSotheyMC. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation. Cancer. 1994;74:2436-2441.
StrazzaboscoMCorneoBLemmoloRM. Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients. J Hepatol. 1997;26:926-934.
20.
NuckolsJDBaronPWStenzelTT. The pathology of liver-localized post-transplant lymphoproliferative disease: a report of three cases and a review of the literature. Am J Surg Pathol. 2000;24:733-741.
21.
CapelloDRasiSOresteP. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients. J Pathol. 2009;218:478-486.
ColomoLLoongFRivesS. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28:736-747.
24.
ValeraABalaguéOColomoL. IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol. 2010;34:1686-1694.
25.
NicolIBoyeTCarsuzaaF. Post-transplant plasmablastic lymphoma of the skin. Br J Dermatol. 2003;149: 889-891.
26.
HanasonoMMParrettBMBreitbartAS. Posttransplant lymphoproliferative disorder presenting as a cutaneous forehead mass. Otolaryngol Head Neck Surg. 2004;130:372-374.
27.
SamolitisNJBharadwajJSWeisJRHarrisRM. Post-transplant lymphoproliferative disorder limited to the skin. J Cutan Pathol. 2004;31:453-457.
28.
Teruya-FeldsteinJChiaoEFilippaDA. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol. 2004;15:1673-1679.
29.
VermaSNuovoGJPorcuPBaiocchiRACrowsonANMagroCM. Epstein-Barr-and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation. J Cutan Pathol. 2005;32:35-39.
30.
ArbiserJLMannKPLoskenEM. Presence of p16 hypermethylation and Epstein-Barr virus infection in transplant-associated hematolymphoid neoplasm of the skin. J Am Acad Dermatol. 2006;55:794-798.
31.
BorensteinJPezzellaFGatterKC. Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorder. Histopathology. 2007;51:774-777.
32.
ApichaiSRogalskaATzvetanovIAsmaZBenedettiEGaitondeS. Multifocal cutaneous and systemic plasmablastic lymphoma in an infant with combined living donor small bowel and liver transplant. Pediatr Transplant. 2009;13:628-631.
33.
HernandezCCetnerASWileyEL. Cutaneous presentation of plasmablastic posttransplant lymphoproliferative disorder in a 14-month-old. Pediatr Dermatol. 2009;26:713-716.
34.
ZimmermannHOschliesIFinkS. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German posttransplant lymphoproliferative disorder registry. Transplantation. 2012;93:543-550.
35.
BlackCLFoster-SmithELewisIDFaullRJSidhuSK. Post-transplant plasmablastic lymphoma of the skin [published online August17, 2012]. Australs J Dermatol. doi:10.1111/j.1440-0960.2012.00939.x.
36.
LambeJSObleDANandulaSV. KHSV(-) EBV(-) post-transplant effusion lymphoma with plasmablastic features: variant of primary effusion lymphoma?Hematol Oncol. 2009;27:203-210.
37.
TestaABaiocchiniAComandiniUV. Fatal sclerosing peritonitis associated with primary effusion lymphoma after liver transplantation: a case report. Transplant Proc. 2010;42:3849-3853.
38.
ShiYHouYHuQSuJZengHTanY. A rare of HHV-8- positive/HIV-negative/EBV-negative primary effusion lymphoma in a renal transplant recipient. Cytopathology. 2012;23:137-139.
39.
Ariza-HerediaEJRazonableRR. Human herpes virus in solid organ transplantation. Transplantation. 2011;92:837-844.
40.
CastilloJJWinerESStachurskiD. HIV-negative plasmablastic lymphoma: not in the mouth. Clin Lymphoma Myeloma Leuk. 2011;12:185-189.
41.
DasanuCABauerFCodrenauIPadmanabhanPRampurwalaM. Plasmablastic haemato-lymphoid neoplasm with complex genetic signature of Burkitt lymphoma responding to bortezomib [published online August17, 2012]. Hematol Oncol. doi:10.10002/hon.2024.
